CCEL (Cryo-Cell International) Owner Earnings per Share (TTM): -0.40 (As of May. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CCEL Cryo-Cell International Inc CCEL
58 GF Score
Price $3.70
GF Value $5.45
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Cryo-Cell International Owner Earnings per Share (TTM)?

Cryo-Cell International CCEL +3.93% 58 Owner Earnings per Share (TTM) is -0.40 as of May. 2026. GuruFocus rates CCEL with a GF Score™ of 58/100 and a GF Value™ of $5.45 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 303 Healthcare Providers & Services companies, Cryo-Cell International ranks worse than 330032.67% on this metric.

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Cryo-Cell International's Owner Earnings per Share (TTM) ended in May. 2026 was $-0.40. It's Price-to-Owner-Earnings ratio for today is 0.


The historical rank and industry rank for Cryo-Cell International's Owner Earnings per Share (TTM) or its related term are showing as below:


During the past 13 years, the highest Price-to-Owner-Earnings ratio of Cryo-Cell International was 109.78. The lowest was 3.88. And the median was 13.10.


CCEL's Price-to-Owner-Earnings is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 17.69
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

Cryo-Cell International's Earnings per Share (Diluted) for the three months ended in May. 2026 was $0.07. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in May. 2026 was $-0.30. It's PE Ratio (TTM) ratio for today is At Loss.

Cryo-Cell International's EPS without NRI for the three months ended in May. 2026 was $0.06. Its EPS without NRI for the trailing twelve months (TTM) ended in May. 2026 was $0.20. It's PE Ratio without NRI ratio for today is 18.88.


Be Aware

Assumption: Companies usually do not report maintenance capital expenditures and growth capital expenditures separately. Here we use estimated numbers and average them over 5 years. The method to estimate maintenance capital expenditures can be found in above part 4.

Note: GuruFocus' Change In Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And it includes non-current parts of assets and liabilities.


Cryo-Cell International Owner Earnings per Share (TTM) Related Terms


Cryo-Cell International Owner Earnings per Share (TTM) Historical Data

* Premium members only.

The historical data trend for Cryo-Cell International's Owner Earnings per Share (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cryo-Cell International Owner Earnings per Share (TTM) Chart

Cryo-Cell International Annual Data
Trend Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23 Nov24 Nov25
Owner Earnings per Share (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.76 0.41 -1.01 -0.24 -0.65

Cryo-Cell International Quarterly Data
Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26 May26
Owner Earnings per Share (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.27 -0.33 -0.65 -0.69 -0.40

CCEL vs EHSI, PIII, CCM: Owner Earnings per Share (TTM) Comparison

For the Medical Care Facilities subindustry, Cryo-Cell International's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cryo-Cell International Price-to-Owner-Earnings vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cryo-Cell International's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Cryo-Cell International's Price-to-Owner-Earnings falls into.


CCEL
58GF Score
Cryo-Cell International Inc CCEL
Owner Earnings per Share (TTM) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cryo-Cell International Owner Earnings per Share (TTM) Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

To make it simple, then you will have:

Owner Earnings per Share (TTM) = (Net Income + Depreciation, Depletion and Amortization + Change In Deferred Tax - 5Y Average of Maintenance Capital Expenditure + Change In Working Capital) / Shares Outstanding (Diluted Average)

Cryo-Cell International's Owner Earnings per Share (TTM) Calculation:

TTM / Last Quarter Average of Last 20 Quarters
Net Income -2.47
Depreciation, Depletion and Amortization 1.37
Change In Deferred Tax 0.00
5Y Average of Maintenance Capital Expenditure 6.03
Change In Working Capital 3.95
Shares Outstanding (Diluted Average) 8.06

1. Start with "Net Income" from income statement. Cryo-Cell International's Net Income for the trailing twelve months (TTM) ended in May. 2026 was $-2.47 Mil.

2. "Depreciation, Depletion and Amortization" is from cashflow statement. Cryo-Cell International's Depreciation, Depletion and Amortization for the trailing twelve months (TTM) ended in May. 2026 was $1.37 Mil. This needs to be added back because company does not actually need to pay cash for it. It is a non-cash item.

3. Other non-cash charges usually include "Stock Based Compensation" and "Change In Deferred Tax":
However, to be conservative, GuruFocus will not add Stock Based Compensation back to net income. Cryo-Cell International's Change In Deferred Tax for the trailing twelve months (TTM) ended in May. 2026 was $0.00 Mil.

4. Average maintenance capital expenditure over a business/industry cycle: 5-Year Average Maintenance Capital Expenditure = $6.03 Mil

It is usually best to take a long-term average of maintenance capital expenditure. Ideally this would be as long as 10 years and include at least one economic downturn. However, since many companies do not have as long as 10-year history, here GuruFocus uses the latest 5 years data to do the calculation. To smooth out unusual years but reflect recent developments, we take an average of the 5 year maintenance capital expenditure.

The following shows how to get maintenance capital expenditure.

First, calculate the revenue change regarding to the previous quarter. If the revenue decreased from the previous quarter, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
Second, if the revenue increased from the previous quarter, then calculate the percentage of Net PPE as of corresponding Revenue.
Growth Capital Expenditure = Percentage of Property, Plant and Equipment as of corresponding Revenue * Revenue Increase
Third, calculate Capital Expenditure (positive) - Growth Capital Expenditure.
If [Capital Expenditure (positive) - Growth Capital Expenditure] was negative, then the Maintenance Capital Expenditure = Capital Expenditure (positive).
If [Capital Expenditure (positive) - Growth Capital Expenditure] was positive, then the Maintenance Capital Expenditure = Capital Expenditure (positive) - Growth Capital Expenditure.
Fourth, get the average of the 5 years maintenance capital expenditure.

Cryo-Cell International's 5-Year Average Maintenance Capital Expenditure = $6.03 Mil

5. "Change In Working Capital" is from cashflow statement. Cryo-Cell International's Change In Working Capital for the trailing twelve months (TTM) ended in May. 2026 was $3.95 Mil.
Note: GuruFocus' Change in Working Capital is provided by Morningstar. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement from original financial report. And sometimes it includes non-current parts of assets and liabilities.

6. Cryo-Cell International's Shares Outstanding (Diluted Average) for the months ended in May. 2026 was 8.055 Mil.

Cryo-Cell International's Onwer Earnings Per Share for May. 2026 is calculated as:

Owner Earnings per Share (TTM)
=( Net Income+Depreciation, Depletion and Amortization+Change In Deferred Tax
=( -2.466 +1.37+0
-5Y Avg of Maintenance CAPEX+Change In Working Capital )/Shares Outstanding (Diluted Average)
-6.0346216370737+3.948)/8.055
=-0.40

Price-to-Owner-Earnings=Current Price/Owner Earnings per Share (TTM)
=3.70/-0.40
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Owner Earnings per Share (TTM) of -0.40 mean?
Cryo-Cell International (CCEL) has a Owner Earnings per Share (TTM) of -0.40 as of May. 2026. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Cryo-Cell International. Over the past decade, Cryo-Cell International's Owner Earnings per Share (TTM) has ranged from 3.88 to 109.78. According to the industry distribution chart, Cryo-Cell International ranks #999999 out of 303 companies in the Healthcare Providers & Services industry.
Is Cryo-Cell International's Owner Earnings per Share (TTM) too high?
Cryo-Cell International's current Owner Earnings per Share (TTM) is -0.40. Over the past 10 years, this metric has ranged from a low of 3.88 to a high of 109.78. Based on the distribution chart, Cryo-Cell International ranks #999999 out of 303 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cryo-Cell International has a GF Score™ of 58/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cryo-Cell International's Owner Earnings per Share (TTM) compare to EHSI and PIII?
According to the Healthcare Providers & Services industry distribution chart, Cryo-Cell International ranks #999999 out of 303 companies for Owner Earnings per Share (TTM). This places Cryo-Cell International in the lower half of its industry. The industry median Owner Earnings per Share (TTM) is 17.69. Historically, Cryo-Cell International's own Owner Earnings per Share (TTM) has ranged from 3.88 to 109.78 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Owner Earnings per Share (TTM) for a Healthcare Providers & Services company?
The median Owner Earnings per Share (TTM) among Healthcare Providers & Services companies is 17.69, based on 303 companies in the industry. Companies in the top quartile (top 25%) have a Owner Earnings per Share (TTM) significantly above this median, while those in the bottom quartile fall well below. However, Owner Earnings per Share (TTM) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Owner Earnings per Share (TTM) mean?
A high Owner Earnings per Share (TTM) can signal that a stock is expensive relative to its fundamentals. Warren Buffett defined owner earnings as reported earnings plus depreciation less average maintenance capital expenditure. View historical data on Cryo-Cell International. For the Healthcare Providers & Services industry, the median Owner Earnings per Share (TTM) is 17.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cryo-Cell International's current Owner Earnings per Share (TTM) is -0.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cryo-Cell International stock overvalued right now?
Based on GuruFocus' analysis, Cryo-Cell International (CCEL) is currently considered Possible Value Trap. The stock's GF Value™ is $5.45, compared to a current price of $3.70 — trading 32.1% below its estimated fair value. The current Owner Earnings per Share (TTM) is -0.40. Cryo-Cell International's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Owner Earnings per Share (TTM) calculated?
Owner Earnings per Share (TTM) is calculated from a company's financial statements. For Cryo-Cell International (CCEL), the current Owner Earnings per Share (TTM) is -0.40 as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cryo-Cell International (CCEL) Overvalued in 2026?

Based on GuruFocus' analysis, Cryo-Cell International stock appears to be undervalued. The current stock price of $3.70 is trading 32.1% below its estimated GF Value™ of $5.45. GuruFocus considers Cryo-Cell International to be Possible Value Trap.

Key valuation signals for CCEL:

  • Owner Earnings per Share (TTM): -0.40
  • GF Value™: $5.45 vs. price of $3.70 (32.1% below fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the CCEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cryo-Cell International Business Description

Other Exchanges ZCY:Germany
Address 700 Brooker Creek Boulevard, Suite 1800, Oldsmar, FL, USA, 34677
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
58GF Score

Get the complete analysis for CCEL

Owner Earnings per Share (TTM) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.70
Price
$5.45
GF Value